Biosimilars Can't Circumvent BPCIA With Litigation

14-12-2013 Law360Comments (0)


The United States District Court for the Northern District of California ruled on Nov. 12, 2013, that a party seeking to obtain approval of a biosimilar could not avoid the process set forth in the ...

Read more on Law360

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top